Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients.

Cappellani, Daniele; Urbani, Claudio; Sardella, Chiara; Scattina, Ilaria; Marconcini, Giulia; Lupi, Isabella; Manetti, Luca; Marcocci, Claudio; Bogazzi, Fausto

Cappellani, Daniele; Urbani, Claudio; Sardella, Chiara; Scattina, Ilaria; Marconcini, Giulia; Lupi, Isabella; Manetti, Luca; Marcocci, Claudio; Bogazzi, Fausto.

Afiliación

Cappellani D; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.
Urbani C; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.
Sardella C; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.
Scattina I; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.
Marconcini G; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.
Lupi I; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.
Manetti L; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.
Marcocci C; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.
Bogazzi F; Unit of Endocrinology Department of Clinical and Experimental Medicine University of Pisa Pisa Italy.

Endocrinol Diabetes Metab ; 2(1): e00033, 2019 Jan.

Article en En | MEDLINE | ID: mdl-30815570

Palabras clave

acromegaly; diabetes mellitus; druginduced diabetes mellitus; growth hormonesecreting pituitary adenoma; somatostatin analogues

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Endocrinol Diabetes Metab Año: 2019 Tipo del documento: Article